Edgewood Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$825K	Hold	15,000	–	–	﹤0.01%	63
2025 Q1	$1.06M	Hold	15,000	–	–	﹤0.01%	65
2024 Q4	$986K	Hold	15,000	–	–	﹤0.01%	65
2024 Q3	$1.05M	Hold	15,000	–	–	﹤0.01%	61
2024 Q2	$1.23M	Hold	15,000	–	–	﹤0.01%	61
2024 Q1	$1.31M	Hold	15,000	–	–	﹤0.01%	56
2023 Q4	$1.45M	Hold	15,000	–	–	﹤0.01%	51
2023 Q3	$1.33M	Hold	15,000	–	–	﹤0.01%	51
2023 Q2	$1.3M	Hold	15,000	–	–	﹤0.01%	53
2023 Q1	$1.46M	Hold	15,000	–	–	﹤0.01%	48
2022 Q4	$1.55M	Hold	15,000	–	–	0.01%	45
2022 Q3	$1.27M	Hold	15,000	–	–	﹤0.01%	43
2022 Q2	$1.24M	Hold	15,000	–	–	﹤0.01%	46
2022 Q1	$1.16M	Hold	15,000	–	–	﹤0.01%	51
2021 Q4	$1.33M	Hold	15,000	–	–	﹤0.01%	50
2021 Q3	$1.16M	Hold	15,000	–	–	﹤0.01%	51
2021 Q2	$1.25M	Hold	15,000	–	–	﹤0.01%	52
2021 Q1	$1.13M	Hold	15,000	–	–	﹤0.01%	52
2020 Q4	$1.32M	Buy	15,000 +5,000	+50%	+$438K	﹤0.01%	46
2020 Q3	$761K	Buy	10,000 +5,000	+100%	+$381K	﹤0.01%	51
2020 Q2	$617K	Hold	5,000	–	–	﹤0.01%	55
2020 Q1	$422K	Hold	5,000	–	–	﹤0.01%	60
2019 Q4	$423K	Buy	+5,000	New	+$423K	﹤0.01%	65
2016 Q4	–	Sell	-11,030	Closed	-$1.02M	–	89
2016 Q3	$1.02M	Buy	11,030 +6,030	+121%	+$558K	0.01%	48
2016 Q2	$389K	Hold	5,000	–	–	﹤0.01%	57
2016 Q1	$412K	Hold	5,000	–	–	﹤0.01%	59
2015 Q4	$524K	Hold	5,000	–	–	﹤0.01%	52
2015 Q3	$527K	Hold	5,000	–	–	﹤0.01%	51
2015 Q2	$684K	Hold	5,000	–	–	0.01%	50
2015 Q1	$623K	Buy	+5,000	New	+$623K	0.01%	52